An abstract net of red and blue fibres stretched tight, like tissue pulled in different directions

"Fasting switches off inflammation." You'll find that line in videos, captions and wellness books, usually delivered as settled fact. And it's an appealing idea — especially if you live with joint pain, a gut condition or anything else where inflammation is the enemy.

So I went looking for the evidence. What I found isn't a yes or a no. It's three different stories, depending on where you look — and one of them points the opposite way.

What the evidence shows

Story one: in the lab, a beautiful mechanism. When you fast, your liver makes ketones — an alternative fuel made from fat. A 2015 study found that the main ketone, beta-hydroxybutyrate, blocks an "alarm switch" inside immune cells called the NLRP3 inflammasome, which helps kick off inflammation. It worked in human immune cells in a dish and in mouse models of inflammatory diseases (Youm et al., Nature Medicine, 2015). The authors suggested this may explain some of the anti-inflammatory effects of eating less. It's elegant science. But cells in a dish and mice are not you.

Story two: during long fasts, inflammation markers often rise. In 2025, researchers in Sydney gathered every human study they could find on fasts of 48 hours or more that measured inflammation — 14 in all (de Ciutiis et al., Ageing Research Reviews, 2025). Contrary to popular belief, as they put it themselves, most found either no change or an increase. CRP — C-reactive protein, a standard inflammation marker in blood tests — frequently went up, often significantly, especially in people carrying extra weight. In several studies it came back down after people started eating again, which suggests the rise may be temporary, perhaps part of the body adapting.

The most extreme example comes from a five-day dry fast — no food and no water — in ten volunteers. Their CRP rose by 167%, almost tripling, even though the authors described the fast as having anti-inflammatory effects (Papagiannopoulos-Vatopaidinos et al., Complementary Medicine Research, 2020).

Story three: shorter, repeated fasting shows promising signals. In Houston, 13 adults with a higher body weight were followed through a month of dawn-to-dusk fasting for Ramadan. Several inflammatory molecules in their blood went down, some staying lower after the month ended (Al Lami et al., Metabolism Open, 2024). It was a tiny observational study with no comparison group — a signal, not proof.

The strongest result is in a real disease. At Stanford, nearly 100 adults with mild-to-moderate Crohn's disease, an inflammatory bowel condition, were randomised to either their usual diet or a five-day "fasting-mimicking diet" — a very low-calorie eating plan — once a month for three months (Kulkarni et al., Nature Medicine, 2026). About 69% of the fasting-diet group improved, against 44% of the others; about 65% reached remission, against 38%. A marker of gut inflammation in stool, calprotectin, fell by 22% in the fasting-diet group while rising 8% in the others.

Why scientists still disagree

Different fasts. Fasting for several days in a row and fasting for a few days each month — or from dawn to dusk — are very different stresses on the body. It's not surprising they push inflammation markers in different directions.

Different markers, different moments. CRP, cytokines and stool calprotectin measure different things. And a blood test taken in the middle of a long fast may tell a different story from one taken a week after eating normally again.

Small and early. The Ramadan study had 13 people and the dry-fasting study ten. The Crohn's trial was well designed but open-label — patients knew which group they were in — and it needs repeating. One of its co-authors is Prof Valter Longo, who developed the fasting-mimicking diet and founded the company that sells it; that's useful context, not a reason to dismiss the result.

What you'll hear online

"Fasting switches off inflammation." The honest version is: some fasting patterns lower some markers in some people — and long fasts often raise CRP, at least for a while.

Before believing any fasting claim, it helps to ask five quick questions:

Five questions before you believe a fasting claim

  1. Was this seen in people, or in mice?
  2. How many people, and for how long?
  3. Compared to what?
  4. Did they measure a real outcome, or a number in the blood?
  5. Does the person telling me this sell something related? (Not an accusation — just useful to know.)

For inflammation, question one does a lot of work. The ketone mechanism you'll hear about is real — in cells and mice. In people, the picture depends on the fast.

What would settle it

Randomised trials in people with a specific inflammatory condition, comparing a fasting pattern with a diet of the same calories, measuring markers both during the fast and after normal eating resumes — and, most importantly, counting real outcomes: flare-ups, symptoms, how much medication people need. The Crohn's trial shows it can be done. It deserves to be repeated, and extended to other conditions.

What you can do

If you live with an inflammatory condition, don't swap your treatment for fasting. If a fasting approach interests you, talk to your doctor about whether it fits — ideally as part of a supervised plan or a trial. And if you have blood tests during or just after a long fast, mention it: your CRP may read higher than usual.

Inflammation is one of the most interesting puzzles in medicine. Fasting may turn out to be part of the answer for some conditions. For now, it's a hypothesis worth testing — not a switch you can flip.

— Dr. Brugal

Voices in the debate

If you'd like to hear the case for fasting from doctors who champion it, these are some of the most influential voices. Their views often go beyond what published human trials have shown so far — which is exactly why it's worth hearing them and checking the studies side by side.

  • Prof Andreas Michalsen — MD PhD, internal and nutritional medicine at Charité Berlin, who combines therapeutic fasting with healthy eating to manage chronic conditions. Book: The Fasting Fix. Penguin Random House
  • Dr Mark Hyman — MD, functional medicine, who presents fasting as a "good stress" that may slow biological ageing. Book: Young Forever. Publishers Weekly
  • Prof Tim Spector — MD, genetic epidemiologist at King's College London and co-founder of ZOE, who suggests a 12 to 14-hour overnight break gives the gut microbiome and gut lining time to rest. Podcast: ZOE Science & Nutrition. ZOE

For the wider debate, see our series guide: Why scientists still can't agree on fasting — and what would settle it. Related: Dry fasting: the trend with almost no evidence — and why that's the real story and Fasting-mimicking diets: science or marketing?.

References

All studies retrieved via PubMed.

  1. Youm YH, Nguyen KY, Grant RW, et al. The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nature Medicine. 2015;21(3):263-9. Laboratory study in human immune cells and mice. doi:10.1038/nm.3804 (PMID 25686106)
  2. de Ciutiis I, Djakovic S, Cagigas ML, et al. Long-term fasting and its influence on inflammatory biomarkers: a comprehensive scoping review. Ageing Research Reviews. 2025;110:102797. Scoping review of 14 human studies (fasts of 48 hours or more). doi:10.1016/j.arr.2025.102797 (PMID 40484176)
  3. Papagiannopoulos-Vatopaidinos IE, Papagiannopoulou M, Sideris V. Dry fasting physiology: responses to hypovolemia and hypertonicity. Complementary Medicine Research. 2020;27(4):242-251. Uncontrolled study, 10 people, 5-day dry fast. doi:10.1159/000505201 (PMID 31958788)
  4. Al Lami Z, Kurtca M, Atique MU, et al. Dawn-to-dusk dry fasting decreases circulating inflammatory cytokines in subjects with increased body mass index. Metabolism Open. 2024;21:100274. Observational study, 13 people, 30 days. doi:10.1016/j.metop.2024.100274 (PMID 38455231)
  5. Kulkarni C, Fardeen T, Gubatan J, et al. A fasting-mimicking diet in patients with mild-to-moderate Crohn's disease: a randomized controlled trial. Nature Medicine. 2026;32(3):1023-1033. Open-label randomised controlled trial, adults with Crohn's disease, 3 months. doi:10.1038/s41591-025-04173-w (PMID 41530382)

Awareness content — not medical advice. Always talk to your doctor or pharmacist before making changes.